Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer.

Hideaki TsuyoshiTetsuya TsujikawaShizuka YamadaHidehiko OkazawaYoshio Yoshida

Published in: EJNMMI research (2020)

[18F]FDG PET/MRI offers better sensitivity and specificity for the characterization and M staging than ceMRI and ceCT, and diagnostic value for T and N staging equivalent to ceMRI and ceCT, suggesting that [18F]FDG PET/MRI might represent a useful diagnostic alternative to conventional imaging modalities in ovarian cancer.

Keyphrases

pet ct
positron emission tomography
contrast enhanced
pet imaging
magnetic resonance imaging
diffusion weighted imaging
computed tomography
high resolution
lymph node